LEADER 03550nam 2200601Ia 450 001 9910139472903321 005 20170815170042.0 010 $a1-282-68281-4 010 $a9786612682810 010 $a3-527-62958-0 010 $a3-527-62959-9 035 $a(CKB)2550000000006848 035 $a(EBL)481246 035 $a(OCoLC)587380638 035 $a(SSID)ssj0000356857 035 $a(PQKBManifestationID)11269912 035 $a(PQKBTitleCode)TC0000356857 035 $a(PQKBWorkID)10350096 035 $a(PQKB)10581696 035 $a(MiAaPQ)EBC481246 035 $a(NjHacI)992550000000006848 035 $a(PPN)164070117 035 $a(EXLCZ)992550000000006848 100 $a20040521d2010 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAtherosclerosis$b[electronic resource] $emolecular and cellular mechanisms /$fedited by Sarah Jane George and Jason Johnson 210 $aWeinheim $cWiley-VCH Verlag GmbH & Co.$d2010 215 $a1 online resource (422 p.) 300 $aDescription based upon print version of record. 311 $a3-527-32448-8 320 $aIncludes bibliographical references and index. 327 $aAtherosclerosis: Molecular and Cellular Mechanisms; Contents; Preface; List of Contributors; PART I: Introduction; 1: Pathogenesis of Atherosclerosis; PART II: PRO-Inflammatory Factors; 2: Chemokines and Atherosclerosis: A Critical Assessment of Therapeutic Targets; 3: Adhesion Molecules and Atherosclerosis; 4: Cytokines and Atherosclerosis; 5: Toll-Like Receptors in Atherosclerosis; 6: PPAR-Based Therapies for the Management of Atherosclerosis; 7: Pentraxins in Vascular Pathology: The Role of PTX3; PART III: Proteases; 8: Metalloproteinases, the Endothelium, and Atherosclerosis 327 $a9: Cathepsins in Atherosclerosis10: The Plasmin System and Atherosclerosis; 11: Mast Cell Proteases and Atherosclerosis; PART IV: Hyperlipidemia; 12: Macrophage Foam Cell Formation: The Pathways to Cholesterol Engorgement; PART V: Oxidative Stress; 13: NADPH Oxidase and Atherosclerosis; 14: Uncoupling of Endothelial Nitric Oxide Synthase in Atherosclerosis; 15: Heme Oxygenase-1 and Atherosclerosis; PART VI: Cell Growth and Phenotype; 16: Phenotypic Heterogeneity of Smooth Muscle Cells-Implications for Atherosclerosis 327 $a17: Platelets: Their Role in Atherogenesis and Thrombosis in Coronary Artery Disease18: Modulators of Monocyte and Macrophage Phenotypes in Atherosclerosis; Index 330 $aWith atherosclerosis being the number one cause of death in the western world, this handbook and ready reference provides a comprehensive account of the different stages and factors in the development of the atherosclerotic plaque. Each chapter is written by experts in the field and highlights the role of specific mediators of atherosclerotic plaque development, as well as potential therapeutic targets. A large amount of this up-to-date information is conveyed by way of tables and schematic figures, in a readily comprehensible manner. A must-have for master and PhD students, researcher 606 $aAtherosclerosis 606 $aArteries$xDiseases 615 0$aAtherosclerosis. 615 0$aArteries$xDiseases. 676 $a616.136 702 $aGeorge$b Sarah Jane 702 $aJohnson$b Jason 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910139472903321 996 $aAtherosclerosis$9729078 997 $aUNINA LEADER 03498nam 2200553 450 001 9910598144303321 005 20230329155418.0 035 $a(CKB)5360000000052181 035 $a(NjHacI)995360000000052181 035 $a(EXLCZ)995360000000052181 100 $a20230329d2021 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$a"Next generation EU" cities $elocal communities in a post-pandemic future /$fedited by Anna Lisa Boni, Andrea Tobia Zevi 210 1$aMilan :$cLedizioni,$d2021. 215 $a1 online resource (157 pages) 311 $a88-5526-612-8 327 $aIntroduction 9 -- 1. The Place of Cities in a Recovering Europe 15 -- PART I. RETHINKING EU CITIES/ THE FUTURE OF CITIES -- 2. Accelerating Urban Climate Neutrality Through National Multi-Stakeholder Platforms: The Case of Spain 35 -- 3. A Fork in the Road: European Cities and Widening Inequalities 55 -- 4. Financing the Low-Carbon Transition in Cities Grant Aaron, Steve Turner 77 -- PART II. CITIES AT WORK -- 5. Towards a Just Digital Transition: Urban Digital Policy in Europe After Covid-19 97 -- 6. The City of the Future for Women - The City of the Future for All 115 -- 7. Culture and Public Space 135 -- About the Authors 153. 330 $aAs the world enters a new year, the Covid-19 pandemic is still upsetting our daily lives. And as 75% of EU citizens live in urban areas, cities are the most prominent stage both for responding to the health crisis, and for seizing opportunities to recover and move forward. Meanwhile, in 2020, EU countries agreed to Next Generation EU, a ?750 billion recovery package that represents a once-in-a-generation opportunity.This report argues that cities should be given more say over how post-pandemic national recovery plans pan out between here and 2026, when all projects are supposed to be wrapping up. Indeed, the success of the EU recovery plans will hinge upon what cities do, or they don't do over the next five years. How are cities rethinking their role within the "twin" green and digital transitions? How can they achieve gender parity, reduce inequalities, and preserve a vibrant cultural life?. 517 $a"Next Generation EU" Cities 517 $aNext generation EU cities 606 $aCity planning$xEnvironmental aspects$zEurope 606 $aCities and towns$zEurope$xHistory$y21st century 606 $aSustainable urban development$zEurope$xHistory$y21st century 606 $aUrban ecology (Sociology)$zEurope$xHistory$y21st century 606 $aUrban policy$zEurope$xHistory$y21st century 606 $aSmart cities$zEurope$xHistory$y21st century 606 $aCOVID-19 Pandemic, 2020-$xSocial aspects 607 $aEuropean Union countries$xEconomic conditions$y21st century 607 $aEurope$xEconomic policy 615 0$aCity planning$xEnvironmental aspects 615 0$aCities and towns$xHistory 615 0$aSustainable urban development$xHistory 615 0$aUrban ecology (Sociology)$xHistory 615 0$aUrban policy$xHistory 615 0$aSmart cities$xHistory 615 0$aCOVID-19 Pandemic, 2020-$xSocial aspects. 676 $a330.94 702 $aBoni$b Anna Lisa 702 $aZevi$b Andrea Tobia 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910598144303321 996 $a"Next generation EU" cities$93086302 997 $aUNINA